Document Detail


No Association of ABCB1 C3435T Genotype With Clopidogrel Response or Risk of Stent Thrombosis in Patients Undergoing Coronary Stenting.
MedLine Citation:
PMID:  22298798     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: The prodrug clopidogrel requires intestinal absorption by the efflux pump P-glycoprotein MDR1 (multidrug resistant-1), encoded by the ABCB1 gene. Prior studies suggested that a common and functional genetic variant (C3435T, rs1045642) within ABCB1 influences clopidogrel treatment efficacy; however, existing data are highly inconsistent, because other studies failed to replicate this postulated association. Thus, the aim of this study was to assess the association of ABCB1 C3435T genotypes with the antiplatelet efficacy of clopidogrel and the risk of stent thrombosis (ST) in large cohorts of clopidogrel-treated patients undergoing percutaneous coronary intervention. METHODS AND RESULTS: DNA samples from 1524 clopidogrel-treated patients undergoing percutaneous coronary intervention were genotyped for ABCB1 C3435T, and ADP-induced platelet aggregation was assessed in whole blood on a Multiplate analyzer. The clinical impact of the genetic variant was investigated by comparison of genotype frequencies in a registry of 66 cases with definite drug-eluting stent ST versus an ST-free control cohort (n=1408). Platelet aggregation values were similar across ABCB1 C3435T genotypes (P=0.73). No significant influence of ABCB1 C3435T genotypes on the occurrence of ST was found when ST case subjects were compared with control subjects (P=0.89). CONCLUSIONS: ABCB1 C3435T genotypes did not influence the antiplatelet response to clopidogrel or the risk of ST in clopidogrel-treated patients undergoing percutaneous coronary intervention. Routine genotyping of ABCB1 C3435T polymorphisms should not be recommended for risk stratification in clopidogrel-treated patients undergoing percutaneous coronary intervention who are similar to those evaluated in the present study.
Authors:
Juliane Jaitner; Tanja Morath; Robert A Byrne; Siegmund Braun; Daniela Gebhard; Isabell Bernlochner; Stefanie Schulz; Julinda Mehilli; Albert Schömig; Werner Koch; Adnan Kastrati; Dirk Sibbing
Related Documents :
1858828 - Cerebrovascular accident complicating acute myocardial infarction: incidence, clinical ...
17223418 - Predictors and outcomes of emergency department visits within 30 days following percuta...
21596318 - Emerging genomic applications in coronary artery disease.
16487848 - Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary ar...
20059668 - Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding.
17138078 - The impact of spontaneous echocardiographic contrast in patients with left atrial enlar...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-31
Journal Detail:
Title:  Circulation. Cardiovascular interventions     Volume:  -     ISSN:  1941-7632     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-2-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101499602     Medline TA:  Circ Cardiovasc Interv     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Deutsches Herzzentrum München and 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Serial Assessment of Coronary Artery Response to Paclitaxel-Eluting Stents Using Optical Coherence T...
Next Document:  Predictors of Periprocedural (Type IVa) Myocardial Infarction, as Assessed by Frequency-Domain Optic...